rs79891110
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_000719.7(CACNA1C):c.1216G>A(p.Gly406Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_000719.7 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399655.6 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.1306G>A | p.Gly436Arg | missense_variant, splice_region_variant | 8/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000347598.9 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399638.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399644.5 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000683482.1 | c.1207G>A | p.Gly403Arg | missense_variant, splice_region_variant | 8/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.1216G>A | p.Gly406Arg | missense_variant, splice_region_variant | 8/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000399603.6 | c.1217+405G>A | intron_variant | 5 | NM_001167623.2 | ENSP00000382512.1 | ||||
CACNA1C | ENST00000406454.8 | c.1217+405G>A | intron_variant | 5 | ENSP00000385896.3 | |||||
CACNA1C | ENST00000399634.6 | c.1217+405G>A | intron_variant | 5 | ENSP00000382542.2 | |||||
CACNA1C | ENST00000683824.1 | c.1307+405G>A | intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000399617.6 | c.1217+405G>A | intron_variant | 5 | ENSP00000382526.1 | |||||
CACNA1C | ENST00000682462.1 | c.1307+405G>A | intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.1307+405G>A | intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.1307+405G>A | intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.1307+405G>A | intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000399641.6 | c.1217+405G>A | intron_variant | 1 | ENSP00000382549.1 | |||||
CACNA1C | ENST00000682835.1 | c.1217+405G>A | intron_variant | ENSP00000507282.1 | ||||||
CACNA1C | ENST00000480911.6 | n.1113+11558G>A | intron_variant | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152054Hom.: 0 Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1312642Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 661428
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74392
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Apr 25, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate G406R reduces channel inactivation, leading to aberrant intracellular calcium levels in multiple tissues (PMID: 15454078); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19074970, 26822303, 23580742, 27593853, 17224476, 29739816, 30027834, 21910241, 23631430, 23678275, 23313911, 21878566, 28211989, 15454078, 30023270, 22581653, 15863612, 16360093, 28718902, 29845439, 30513141, 30530868, 31737537, 34079780, 28371864, 27034553, 23690510, 31805042, 32161207, 27868338, 30384889, 30998997, 31395954) - |
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Timothy syndrome Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | Classic Timothy syndrome phenotype - |
Pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Apr 04, 2018 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 10, 2011 | - - |
Timothy syndrome;C2678478:Brugada syndrome 3;C5774213:Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures;CN260585:Long qt syndrome 8 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Dec 21, 2022 | This variant, located in the alternatively spliced exon 8A of the CACNA1C gene, is a well-established pathogenic variant that is referenced in the GeneReviews article for CACNA1C-Related Disorders as the predominant cause of classic Timothy syndrome (Napolitano 2021 PMID: 20301577). It has been reported in the literature and in ClinVar in numerous individuals with Timothy syndrome, including several instances of this variant as either de novo or mosaic; additionally, multiple individuals are reported to have inherited this variant from unaffected or mildly affected parents as a result of low-level somatic and/or germline mosaicism (Selected publications: Splawski 2004 PMID: 15454078; Etheridge 2011 PIMD: 21910241; Dufendach 2013 PMID: 23690510; Kawaida 2016 PMID: 27593853; Walsh 2018 PIMD: 28371864; ClinVar Variation ID: 17632). It is present in a single heterozygote in the Genome Aggregation Database (Highest reported MAF: 0.02% [1/4784]; https://gnomad.broadinstitute.org/variant/12-2504944-G-A?dataset=gnomad_r3); please note, disease-causing variants may be present in control databases at low frequencies, reflective of the general population, incomplete penetrance, and/or variable expressivity. In vitro functional studies demonstrate a deleterious effect of this variant on calcium channel function (Selected publications: Splawski 2004 PMID: 15454078; Yarotskyy 2009 PMID: 19074970). A mouse model with this variant recapitulated various abnormal neurodevelopmental features seen in individuals with Timothy syndrome (Bader 2011 PIMD: 21878566). Evolutionary conservation and computational prediction tools strongly support that this variant impacts the protein. In summary, this variant is classified as pathogenic. - |
CACNA1C-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Feb 13, 2019 | This variant is located in the last amino acid of exon 8. This variant has been previously reported in multiple studies as a de novo heterozygous change in patients with Timothy Syndrome (PMID: 28371864, 23690510, 28211989, 15454078). A functional study showed this variant impairs voltage-dependent channel inactivation causing maintained inward calcium currents (PMID: 15454078). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. The c.1216G>A (p.Gly406Arg) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.1216G>A (p.Gly406Arg) variant is classified as pathogenic. - |
Long qt syndrome 8 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 16, 2024 | - - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 406 of the CACNA1C protein (p.Gly406Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Timothy syndrome (PMID: 15454078, 15863612, 21910241, 23578275, 23580742, 23690510, 26227324). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 17632). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Experimental studies have shown that this missense change affects CACNA1C function (PMID: 15454078, 15863612, 18250309, 19074970, 26822303). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2022 | The p.G406R pathogenic mutation (also known as c.1216G>A), located in coding exon 8A of the CACNA1C gene, results from a G to A substitution at nucleotide position 1216. The glycine at codon 406 is replaced by arginine, an amino acid with dissimilar properties. This mutation has been detected in numerous individuals with Timothy syndrome (TS), including de novo cases and those due to parental mosaicism; incomplete TS has been described in some cases of somatic mosaicism with this mutation (Splawski I et al. Cell, 2004 Oct;119:19-31; Etheridge SP et al. Am. J. Med. Genet. A, 2011 Oct;155A:2578-83; An HS et al. J. Korean Med. Sci., 2013 May;28:788-91;Dufendach KA et al. Pediatrics, 2013 Jun;131:e1991-5; Walsh MA et al. Europace, 2018 02;20:377-385). Functional studies demonstrated altered gating kinetics and prolonged action potential duration, while mouse models with this mutation showed neurobehavioral and brain changes consistent with TS clinical findings (Splawski I et al. Cell, 2004 Oct;119:19-31; Bader PL et al. Proc. Natl. Acad. Sci. U.S.A., 2011 Sep;108:15432-7; Krey JF et al. Nat. Neurosci., 2013 Feb;16:201-9). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported in the following publications (PMID:15454078;PMID:15863612;PMID:17224476;PMID:19074970;PMID:21878566). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at